148
Views
2
CrossRef citations to date
0
Altmetric
Research Reports

Absence of significant genetic alterations in the VSX1, SOD1, TIMP3, and LOX genes in Brazilian patients with Keratoconus

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 73-79 | Received 05 May 2021, Accepted 04 Oct 2021, Published online: 22 Nov 2021

References

  • Jiménez JLO, Jurado JCG, Rodriguez FJB, Laborda DS. Keratoconus: age of onset and natural history. Optom Vis Sci. 1997 Mar;74(3):147–51. doi:10.1097/00006324-199703000-00025.
  • Rabinowitz YS. Keratoconus. Surv Ophthalmol. 1998 Jan;42(4):297–319. doi:10.1016/S0039-6257(97)00119-7.
  • Mas Tur V, MacGregor C, Jayaswal R, O’Brart D, Maycock N. A review of Keratoconus: diagnosis, pathophysiology, and genetics. Surv Ophthalmol. 2017 Nov;62(6):770–83. doi:10.1016/j.survophthal.2017.06.009.
  • Weiss JS, Møller HU, Aldave AJ, Seitz B, Bredrup C, Kivelä T, et al. IC3D classification of corneal dystrophies-edition 2. Cornea. 2015 Feb;34(2):117–59. doi:10.1097/ICO.0000000000000307.
  • Hashemi H, Heydarian S, Hooshmand E, Saatchi M, Yekta A, Aghamirsalim M, et al. The prevalence and risk factors for Keratoconus: a systematic review and meta-analysis. Cornea. 2020 Feb;39(2):263–70. doi:10.1097/ICO.0000000000002150.
  • Moazzeni H, Javadi MA, Asgari D, Khani M, Emami M, Moghadam A, Panahi-Bazaz, MR, Tehrani, MH, Karimian, F, and Hosseini, B. Observation of nine previously reported and 10 non-reported SLC4A11 mutations among 20 Iranian CHED probands and identification of an MPDZ mutation as possible cause of CHED and FECD in one family. Br J Ophthalmol. 2019;e314377. doi:10.1136/bjophthalmol-2019-314377.
  • Pinheiro-Costa J, Viana Pinto J, Perestrelo S, Beato JN, Torrão L, Brandão E, Carneiro Â, Madeira MD, and Falcão-Reis F . Increased choroidal thickness in Keratoconus patients: perspectives in the disease pathophysiology. J Ophthalmol. 2019;2019:1–7. doi:10.1155/2019/2453931.
  • Ghassembaglou N, Djalilian AR. Keratoconus; A true corneal disease. J Ophthalmic Vis Res. 2016 Jan;11(1):1–2. doi:10.4103/2008-322X.180701.
  • Bykhovskaya Y, Margines B, Rabinowitz YS. Genetics in Keratoconus: where are we? Eye Vis. 2016 Dec;3(1):1–10. doi:10.1186/s40662-016-0047-5.
  • Moussa S, Grabner G, Ruckhofer J, Dietrich M, Reitsamer H. Genetics in Keratoconus – what is new? Open Ophthalmol J. 2017 Jul;11(1):201–10. doi:10.2174/1874364101711010201.
  • Galvis V, Tello A, Carreño NI, Berrospi RD, Niño CA. Risk factors for Keratoconus: atopy and eye rubbing. Cornea. 2017 Jan;36(1):e1. doi:10.1097/ICO.0000000000001052.
  • Ben-Eli H, Erdinest N, and Solomon A. Pathogenesis and complications of chronic eye rubbing in ocular allergy. Lippincott Williams and Wilkins; 2019 doi:10.1097/ACI.0000000000000571.
  • Zagora SL, Cornish EE, Symes RJ, Younan C, Sammel A, Wakefield D, and McCluskey P . Inflammatory eye and rheumatic disease. Int J Rheum Dis. 2019 Dec;22(12):2091–95. doi:10.1111/1756-185X.13714.
  • Barrientez B, Nicholas SE, Whelchel A, Sharif R, Hjortdal J, Karamichos D. Corneal injury: clinical and molecular aspects. Exp Eye Res. 2019 Sep;186:107709. doi:10.1016/j.exer.2019.107709.
  • Najmi H. The correlation between Keratoconus and eye rubbing: a review. Int J Ophthalmol. 2019 Nov;12(11):1775–81. doi:10.18240/ijo.2019.11.17.
  • Rafati S, Hashemi H, Nabovati P, Doostdar A, Yekta A, and Aghamirsalim M, Khabazkhoob M. Demographic profile, clinical, and topographic characteristics of Keratoconus patients attending at a tertiary eye center. J Curr Ophthalmol. 2019;31(3):268–74.doi:10.1016/j.joco.2019.01.013.
  • Malfeito M, Regueiro U, Pérez-Mato M, Campos F, Sobrino T, Lema I. Innate immunity biomarkers for early detection of Keratoconus. Ocul Immunol Inflamm. 2019;27(6):942–48.doi:10.1080/09273948.2018.1511813.
  • Nabil KM, Elhady GM, Morsy H. The association between interleukin 1 beta promoter polymorphisms and Keratoconus incidence and severity in an Egyptian population. Clin Ophthalmol. 2019;13:2217–23.doi:10.2147/OPTH.S220723.
  • Loukovitis E, Sfakianakis K, Syrmakesi P, Tsotridou E, Orfanidou M, and Bakaloudi DR, Stoila M, Kozei A, Koronis S, Zachariadis Z, et al. Genetic aspects of Keratoconus: a literature review exploring potential genetic contributions and possible genetic relationships with comorbidities. Ophthalmol Ther. 2018 Dec;7(2):263–92. doi:10.1007/s40123-018-0144-8.
  • Khawaja AP, Rojas Lopez KE, Hardcastle AJ, Hammond CJ, Liskova P, Davidson AE, Gore DM, Hafford Tear NJ, Pontikos N, Hayat S, et al. Genetic variants associated with corneal biomechanical properties and potentially conferring susceptibility to Keratoconus in a genome-wide association study. JAMA Ophthalmol. 2019 Sep;137(9):1005–12. doi:10.1001/jamaophthalmol.2019.2058.
  • Skorodumova LO, Belodedova AV, Sharova EI, and Malyugin BE. Search for genetic markers for precise diagnostics of Keratoconus. Biochem Suppl Ser B 18 Biomed Chem. 2019;13(3):214–27. doi:10.18097/PBMC20196501009.
  • Gadelha DNB, Feitosa AFB, da Silva RG, Antunes LT, Muniz MC, de Oliveira MA, Andrade DO, da Paz Silva NM, Cronemberger S, Schamber-Reis BLF . Screening for novel LOX and SOD1 variants in Keratoconus patients from Brazil. J Ophthalmic Vis Res. 2020 Apr;15(2):138–48. doi:10.18502/jovr.v15i2.6730.
  • Lucas SEM, Zhou T, Blackburn NB, Mills RA, Ellis J, Leo P, Souzeau E, Ridge B, Charlesworth JC, Lindsay R, et al. Rare, potentially pathogenic variants in 21 Keratoconus candidate genes are not enriched in cases in a large Australian cohort of European descent. PLoS One. 2018 Jun;13(6):e0199178. doi:10.1371/journal.pone.0199178.
  • Atilano S, Lee D, Fukuhara P, Chwa M, Nesburn A, Udar N, and Kenney C . Corneal oxidative damage in Keratoconus cells due to decreased oxidant elimination from modified expression levels of SOD enzymes, PRDX6, SCARA3, CPSF3, and FOXM1. J Ophthalmic Vis Res. 2019 Jan;14(1):62–70. doi:10.4103/jovr.jovr_80_18.
  • Saee-Rad S, Raoofian R, Mahbod M, Miraftab M, Mojarrad M, and Asgari S, Rezvan F, Hashemi H . Analysis of superoxide dismutase 1, dual-specificity phosphatase 1, and transforming growth factor, beta 1 genes expression in keratoconic and non-keratoconic corneas. Mol Vis. 2013 Dec;19:2501–07.
  • Elmohamady MN, Abdelghaffar W, Salem TI. Tear Martix Metalloproteinase-9 and Tissue Inhibitor of Metalloproteinase-1 in Post-Lasik Ectasia. Int Ophthalmol. 2019 Mar;39(3):631–37. doi:10.1007/s10792-018-0861-y.
  • di Martino E, Ali M, Inglehearn CF. Matrix metalloproteinases in Keratoconus – too much of a good thing? Exp Eye Res. 2019 May;182:137–43. doi:10.1016/j.exer.2019.03.016.
  • Yu C, Chen H, Qi X, Chen P, Di G. Annexin A1 mimetic peptide Ac2-26 attenuates mechanical injury induced corneal scarring and inflammation. Biochem Biophys Res Commun. 2019 Nov;519(2):396–401. doi:10.1016/j.bbrc.2019.09.020.
  • Liu B, Li A, Wang H, Wang J, Zhai G, and Ma H, Feng S, Liu L, Gao Y . Exploring the key genes and pathways in the formation of corneal scar using bioinformatics analysis. Biomed Res Int. 2020 Jan;2020:6247489. doi:10.1155/2020/6247489.
  • Greene CA, Green CR, Dickinson ME, Johnson V, Sherwin T. Keratocytes are induced to produce collagen type II: a new strategy for in vivo corneal matrix regeneration. Exp Cell Res. 2016 Sep;347(1):241–49. doi:10.1016/j.yexcr.2016.08.010.
  • de Bonis P, Laborante A, Pizzicoli C, Stallone R, Barbano R, and Longo C, Mazzilli E, Zelante L, Bisceglia L. Mutational screening of VSX1, SPARC, SOD1, LOX, and TIMP3 in Keratoconus. Mol Vis. 2011 Sep;17:2482–94.
  • Panahi Y, Azimi A, Naderi M, Jadidi K, Sahebkar A. An analytical enrichment-based review of structural genetic studies on Keratoconus. J Cell Biochem. 2019 Apr;120(4):4748–56. doi:10.1002/jcb.27764.
  • Loukovitis E, Kozeis N, Gatzioufas Z, Kozei A, Tsotridou E, Stoila M, Koronis S, Sfakianakis K, Tranos P, Balidis M, et al. The proteins of Keratoconus: a literature review exploring their contribution to the pathophysiology of the disease. Adv Ther. 2019 Sep;36(9):2205–22. doi:10.1007/s12325-019-01026-0.
  • Ambrósio R, Lopes BT, Faria-Correia F, Salomão MQ, Bühren J, Roberts CJ, Elsheikh A, Vinciguerra R, and Vinciguerra . Integration of scheimpflug-based corneal tomography and biomechanical assessments for enhancing ectasia detection. J Refract Surg. 2017;33(7):434–43.doi:10.3928/1081597X-20170426-02.
  • Zadnik K, Barr JT, Edrington TB, Everett DF, Jameson M, and McMahon TT, Shin JA, Sterling JL, Wagner H, Gordon MO . Baseline findings in the collaborative longitudinal evaluation of Keratoconus (CLEK) study. Investig Ophthalmol Vis Sci. 1998 Dec;39(13):2537–46.
  • Bisceglia L, Ciaschetti M, De Bonis P, Campo PAP, Pizzicoli C, and Scala C, Grifa M, Ciavarella P, Delle Noci N, Vaira F, Macaluso C, et al. VSX1 mutational analysis in a series of Italian patients affected by Keratoconus: detection of a novel mutation. Investig Ophthalmol Vis Sci. 2005 Jan;46(1):39–45. doi:10.1167/iovs.04-0533.
  • Udar N, Atilano SR, Brown DJ, Holguin B, Small K, and Nesburn AB, Kenney MC. SOD1: a candidate gene for Keratoconus. Investig Ophthalmol Vis Sci. 2006 Aug;47(8):3345–51. doi:10.1167/iovs.05-1500.
  • Guan T, Wang X, Zheng LB, Wu HJ, Yao YF. Analysis of the VSX1 gene in sporadic Keratoconus patients from China. BMC Ophthalmol. 2017 Sep;17(1):173. doi:10.1186/s12886-017-0567-3.
  • Orita M, Suzuki Y, Sekiya T, Hayashi K. Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics. 1989 Nov;5(4):874–79. doi:10.1016/0888-7543(89)90129-8.
  • Orita M, Iwahana H, Kanazawa H, Hayashi K, Sekiya T. Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. Proc Natl Acad Sci USA. 1989;86(8):2766–70.doi:10.1073/pnas.86.8.2766.
  • Valgaeren H, Koppen C, Van Camp G. A new perspective on the genetics of Keratoconus: why have we not been more successful? Ophthalmic Genet. 2018 Mar;39(2):158–74. doi:10.1080/13816810.2017.1393831.
  • Ilhan A, Altun S, Durukan I, Yolcu U, Erdem U. The association between genetic polymorphism of glutathione peroxidase 1 (rs1050450) and Keratoconus in a Turkish population. Arq Bras Oftalmol. 2019;82(6):501–06.doi:10.5935/0004-2749.20190102.
  • Khaled ML, Bykhovskaya Y, Gu C, Liu A, Drewry MD, Chen Z, Mysona BA, Parker E, McNabb RP, Yu H, et al. PPIP5K2 and PCSK1 are candidate genetic contributors to familial Keratoconus. Sci Rep. 2019 Dec;9(1):1–16. doi:10.1038/s41598-019-55866-5.
  • Štabuc-Šilih M, Stražišar M, Hawlina M, Glavač D. Absence of pathogenic mutations in VSX1 and SOD1 genes in patients with Keratoconus. Cornea. 2010 Feb;29(2):172–76. doi:10.1097/ICO.0b013e3181aebf7a.
  • Al-Muammar AM, Kalantan H, Azad TA, Sultan T, Abu-Amero KK. Analysis of the SOD1 gene in Keratoconus patients from Saudi Arabia. Ophthalmic Genet. 2015 Dec;36(4):373–75. doi:10.3109/13816810.2014.889173.
  • Anzai I, Tokuda E, Handa S, Misawa H, Akiyama S, Furukawa Y. Oxidative misfolding of Cu/Zn-superoxide dismutase triggered by non-canonical intramolecular disulfide formation. Free Radic Biol Med. 2020 Feb;147:187–99. doi:10.1016/j.freeradbiomed.2019.12.017.
  • Al-Raddadi HS, Al-Barry MA, Al-Harbi E, Samman MI, Albalawi AM, and Basit S. Sequence analysis of the VSX1 and SOD1 genes in families with Keratoconus and a review of the literature. J Taibah Univ Med Sci. 2016 Apr;11(2):115–20. doi:10.1016/j.jtumed.2015.08.004.
  • Montllor-Albalate C, Colin AE, Chandrasekharan B, Bolaji N, Andersen JL, and Wayne Outten F, Reddi AR . Extra-mitochondrial Cu/Zn superoxide dismutase (Sod1) is dispensable for protection against oxidative stress but mediates peroxide signaling in Saccharomyces cerevisiae. Redox Biol. 2019 Feb;21:101064. doi:10.1016/j.redox.2018.11.022.
  • Lewandowski Ł, Kepinska M, Milnerowicz H. The copper-zinc superoxide dismutase activity in selected diseases. Eur J Clin Invest. 2019 Jan;49(1):e13036. doi:10.1111/eci.13036.
  • Khaled ML, Helwa I, Drewry M, Seremwe M, Estes A, Liu Y. Molecular and histopathological changes associated with Keratoconus. Biomed Res Int. 2017 Jul;2017(1):7803029. doi:10.1155/2017/7803029.
  • Wang YN, Liu XN, Wang XD, Yin Y, Chen Y, and Xiao XH, Xu K, Zhu XP . Expression of visual system homeobox 1 in human Keratoconus. Int J Ophthalmol. 2019 Feb;12(2):201–06. doi:10.18240/ijo.2019.02.03.
  • Markitantova Y, Simirskii V. Inherited eye diseases with retinal manifestations through the eyes of homeobox genes. Int J Mol Sci. 2020 Feb;21(5):1602. doi:10.3390/ijms21051602.
  • Héon E, Greenberg A, Kopp KK, Rootman D, Vincent AL, and Billingsley G, Priston M, Dorval KM, Chow RL, McInnes RR, et al . VSX1: a gene for posterior polymorphous dystrophy and Keratoconus. Hum Mol Genet. 2002 May;11(9):1029–36. doi:10.1093/hmg/11.9.1029.
  • Litke AM, Samuelson S, Delaney KR, Sauvé Y, Chow RL. Investigating the pathogenicity of VSX1 missense mutations and their association with corneal disease. Investig Ophthalmol Vis Sci. 2018;59(15):5824–35.doi:10.1167/iovs.18-25490.
  • Shetty R, Nuijts RMMA, Nanaiah SG, Anandula VR, Ghosh A, and Jayadev C, Pahuja N, Kumaramanickavel G, Nallathambi J . Two novel missense substitutions in the VSX1 gene: clinical and genetic analysis of families with Keratoconus from India. BMC Med Genet. 2015 Dec;16(1):33. doi:10.1186/s12881-015-0178-x.
  • Da Silva DC, Gadelha BNB, Feitosa AFB, Da Silva RG, Albuquerque TLPE, and Santos DCPF, Gadelha DNB, Fonseca Schamber-Reis BL . Analysis of VSX1 variations in Brazilian subjects with Keratoconus. J Ophthalmic Vis Res. 2018 Jul;13(3):266–73. doi:10.4103/jovr.jovr_116_17.
  • Moschos MM, Kokolakis N, Gazouli M, Chatziralli IP, Droutsas D, and Anagnou NP, Ladas ID . Polymorphism analysis of VSX1 and SOD1 genes in Greek patients with Keratoconus. Ophthalmic Genet. 2015 Jul;36(3):213–17. doi:10.3109/13816810.2013.843712.
  • Sharif R, Fowler B, Karamichos D. Collagen cross-linking impact on Keratoconus extracellular matrix. PLoS One. 2018 Jul;13(7):e0200704. doi:10.1371/journal.pone.0200704.
  • Fields GB. The rebirth of matrix metalloproteinase inhibitors: moving beyond the Dogma. Cells. 2019;Aug(9):984. doi:10.3390/cells8090984.
  • Rodríguez C, Martínez-González J. The role of lysyl oxidase enzymes in cardiac function and remodeling. Cells. 2019 Nov;8(12):1483. doi:10.3390/cells8121483.
  • Chen L, Li S, Li W. LOX/LOXL in pulmonary fibrosis: potential therapeutic targets. J Drug Target. 2019 Aug;27(7):790–96. doi:10.1080/1061186X.2018.1550649.
  • Vallet SD, Ricard-Blum S. Lysyl oxidases: from enzyme activity to extracellular matrix cross-links. Essays Biochem. 2019 Sep;63(3):349–64. doi:10.1042/EBC20180050.
  • Dudakova L, Liskova P, Trojek T, Palos M, Kalasova S, Jirsova K. Changes in lysyl oxidase (LOX) distribution and its decreased activity in Keratoconus corneas. Exp Eye Res. 2012 Nov;104:74–81. doi:10.1016/j.exer.2012.09.005.
  • Hasanian-Langroudi F, Saravani R, Validad MH, Bahari G, Yari D. Association of Lysyl oxidase (LOX) polymorphisms with the risk of Keratoconus in an Iranian population. Ophthalmic Genet. 2015 Dec;36(4):309–14. doi:10.3109/13816810.2014.881507.
  • Zhang J, Zhang L, Hong J, Wu D, Xu J. Association of common variants in LOX with Keratoconus: a meta-analysis. PLoS One. 2015 Dec;10(12):e0145815. doi:10.1371/journal.pone.0145815.
  • Magalhães OA, Kowalski TW, Wachholz GE, Schuler-Faccini L. Whole-exome sequencing in familial Keratoconus: the challenges of a genetically complex disorder. Arq Bras Oftalmol. 2019;82(6):453–59.doi:10.5935/0004-2749.20190087.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.